絞り込み

16546

広告

1033件中 121件~140件表示    検索結果をPubMedで見る PubMedで見る

Blocking of the EGFR-STAT3 signaling pathway through afatinib treatment inhibited the intrahepatic cholangiocarcinoma.

Machine learning identifies a core gene set predictive of acquired resistance to EGFR tyrosine kinase inhibitor.

Budget Impact Analysis of Afatinib for First-Line Treatment of Patients with Metastatic Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Exon 19 Deletions or Exon 21 Substitution Mutations in a U.S. Health Plan.

Miliary Adenocarcinoma of the Lung Responds to Gefitinib and Afatinib.

Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors.

Tyrosine kinase inhibitors for brain metastases in HER2-positive breast cancer.

Challenges of dispensing costly tablets with short shelf-life.

Antibody-assisted target identification reveals afatinib, an EGFR covalent inhibitor, down-regulating ribonucleotide reductase.

First-Line Treatment in EGFR Mutant Non-Small Cell Lung Cancer: Is There a Best Option?

Anti-Epidermal Growth Factor Vaccine Antibodies Enhance the Efficacy of Tyrosine Kinase Inhibitors and Delay the Emergence of Resistance in EGFR Mutant Lung Cancer Cells.

Cost-effectiveness analysis of policy options on first-line treatments for advanced, non-small cell lung cancer in Thailand.

Effectiveness of afatinib after ineffectiveness of gefitinib in an advanced lung adenocarcinoma patient with a single EGFR exon 20 S768I mutation: a case report.

Application of molecular targeted therapies in the treatment of head and neck squamous cell carcinoma.

Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFR NSCLC in diagnosis, follow-up and treatment.

Transformation to small cell lung cancer after first-line afatinib treatment.

Acquired T790M Mutation After Relapse Following EGFR-TKI Therapy: A Population-based Multi-institutional Study.

Tyrosine Kinase Inhibition in HPV-related Squamous Cell Carcinoma Reveals Beneficial Expression of cKIT and Src.

Sleeve lobectomy for lung adenocarcinoma treated with neoadjuvant afatinib.

Afatinib in Osimertinib-Resistant EGFR ex19del / T790M / P794L mutated Non-Small Cell Lung Cancer.

  1. 3
  2. 4
  3. 5
  4. 6
  5. 7
  6. 8
  7. 9
  8. 10
  9. 11
  10. 12
Sort by
※並べ替えは表示に時間がかかります